MOUNT VERNON, Wash., May 20 /PRNewswire/ -- PreViser Corporation (http://www.previser.com), a Washington State-based provider of patented oral disease and risk assessment technology to the dental profession, announced today the finalization of a licensing agreement with Oral Health Innovations (OHI) Ltd (http://www.previser.co.uk) of Birmingham, England to market PreViser technology to dentists within the United Kingdom and the Republic of Ireland.
OHI Ltd is a joint venture with the University of Birmingham. Following a successful pilot, OHI will launch PreViser at a Denplan-sponsored seminar for its Excel accredited practitioners in June 2008. Discussions are also underway with a number of Primary Care Trusts on how the technology can be used as a best practice tool within National Health Service (NHS) dentistry.
Iain Chapple, Professor of Periodontology and Consultant in Restorative Dentistry, who runs an NHS referral center serving approximately six million patients, acts as adviser to OHI Ltd. Prof. Chapple commented, "PreViser is unique in its web-based approach to risk and disease scoring and has a scientific evidence base behind its efficacy. However, one of its biggest benefits is the immediate and personalized biofeedback it offers to patients. We all know that successful periodontal therapy is founded on patient education and compliance with home care regimes. PreViser is a most innovative tool that motivates patients to take personal responsibility for their own oral health.
"In addition to the obvious patient and practitioner benefits, PreViser allows oral healthcare funders to focus their resources towards those that need it most and provides a platform from which to deliver truly preventative oral care in a cost effective manner.
"As a teacher, it is exciting to be able to utilize the system, which
is provided fr
|SOURCE PreViser Corporation|
Copyright©2008 PR Newswire.
All rights reserved